08 Feb

MSD – New Hydrogenator EPC


MSD is one of the top five biopharmaceutical companies in the UK and employs over 2000 people across five sites. The company has been researching, developing and supplying new medicines and vaccines to prevent and treat disease for over 80 years.


HFL provided a new hydrogenator, synthesis reactor and bay fit-out for a new drug discovery pilot plant at the MSD Centre of Excellence. The project was fully validated by HFL and was undertaken on an EPC basis.